Prognostic significance of tumor-infiltrating lymphocytes (TILs) in patients with early-stage triple-negative breast cancer (TNBC) treated with curative resection alone

被引：0
|
作者：
Park, J. H. [1 ]
Lee, H. J. [2 ]
Ahn, J-H. [1 ]
Kim, J. E. [1 ]
Jung, K. H. [1 ]
Gong, G. [2 ]
Kim, S-B. [1 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Med Oncol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Pathol, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
72P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prognostic Assessment of Stromal and Non-Stromal Tumor-Infiltrating Lymphocytes (TILs) in Triple-Negative Breast Cancer (TNBC)
    Ghosh, Toshi
    Goetz, Matthew
    Leon-Ferre, Roberto A.
    Liu, Heshan
    Polley, Mei-Yin C.
    Ingle, James
    Cafourek, Victoria L.
    Hillman, David W.
    Carter, Jodi
    Visscher, Daniel
    LABORATORY INVESTIGATION, 2018, 98 : 61 - 62
  • [2] Prognostic Assessment of Stromal and Non-Stromal Tumor-Infiltrating Lymphocytes (TILs) in Triple-Negative Breast Cancer (TNBC)
    Ghosh, Toshi
    Goetz, Matthew
    Leon-Ferre, Roberto A.
    Liu, Heshan
    Polley, Mei-Yin C.
    Ingle, James
    Cafourek, Victoria L.
    Hillman, David W.
    Carter, Jodi
    Visscher, Daniel
    MODERN PATHOLOGY, 2018, 31 : 61 - 62
  • [3] Spatial organization of tumor-infiltrating lymphocytes (TILs) is prognostic for survival in triple negative breast cancer (TNBC)
    Patel, Sahil H.
    Corredor, German
    Yoder, Rachel
    Barrera, Cristian
    Castillo, Miluska
    Bernabe, Luis
    Staley, Joshua
    Stecklein, Shane
    Viswanath, Satish E.
    Castaneda, Carlos A.
    Sharma, Priyanka
    Madabhushi, Anant
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Prognostic and predictive value of tumor-infiltrating lymphocytes (TILs) in triple-negative breast cancers (TNBC) treated with neoadjuvant chemotherapy (NAC)
    Herrero-Vicent, C.
    Guerrero, A.
    Gavila, J.
    Gozalbo, F.
    Blanch, S.
    Hernandez, A.
    Sandiego, S.
    Calatrava, A.
    Guillem, V.
    Ruiz, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Intrinsic Prognostic Impact of Tumor-infiltrating Lymphocytes in Systemically Untreated Patients With Early-stage Triple-negative Breast Cancer
    Park, Ji Hyun
    Lee, Hee Jin
    Lee, Sae Byul
    Ahn, Jin-Hee
    Kim, Jeong Eun
    Jung, Kyung Hae
    Gong, Gyungyub
    Son, Byung-Ho
    Ahn, Sei-Hyun
    Kim, Sung-Bae
    ANTICANCER RESEARCH, 2019, 39 (06) : 3111 - 3119
  • [6] Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy
    Park, J. H.
    Jonas, S. F.
    Bataillon, G.
    Criscitiello, C.
    Salgado, R.
    Loi, S.
    Viale, G.
    Lee, H. J.
    Dieci, M. V.
    Kim, S. -B.
    Vincent-Salomon, A.
    Curigliano, G.
    Andre, F.
    Michiels, S.
    ANNALS OF ONCOLOGY, 2019, 30 (12) : 1941 - 1949
  • [7] Nivolumab and ipilimumab in early-stage triple negative breast cancer (TNBC) with tumor-infiltrating lymphocytes (TILs): First results from the BELLINI trial
    Nederlof, I.
    Isaeva, O. I.
    Bakker, N.
    de Graaf, M.
    Salgado, R. F.
    Klioueva, N.
    Van De Vijver, K.
    van Duijnhoven, F.
    Kalashnikova, E.
    Willingham, S.
    Luykx, S.
    Loo, C. E.
    Kerver, E.
    Sonke, G. S.
    Blank, C. U.
    Mann, R.
    Linn, S. C.
    Lambrechts, D.
    Horlings, H.
    Kok, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1382 - S1382
  • [8] Tumor-infiltrating lymphocytes (TILs) is associated with improved overall survival in triple-negative breast cancer (TNBC) patients treated with neoadjuvant chemotherapy (NAC)
    Sampaio, Cd D. A. T.
    de Lima, V. C. C.
    de Andrade, V. P.
    Neotti, T.
    Tavares, M. C.
    Sessa, V. A.
    Calsavara, V. F.
    Zenun, G. R.
    Giongo, A. A.
    da Costa, A. A. B. A.
    CANCER RESEARCH, 2017, 77
  • [9] Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer
    Tu, Hengjia
    Zhang, Yuzhuo
    You, Zhixuan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (04):
  • [10] Prognostic value of tumour infiltrating lymphocytes (TILs) in patients with early-stage triple negative breast cancers (TNBC) in the absence of chemotherapy
    Park, J. H.
    Jonas, S. F.
    Dieci, M. V.
    Bataillon, G.
    Criscitiello, C.
    Viale, G.
    Salgado, R. F.
    Lee, H. J.
    Loi, S.
    Kim, S. -B.
    Curigliano, G.
    Vincent-Salomon, A.
    Andre, F.
    Michiels, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 55 - 55
12345